Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Cases Having a Gleason Score 3+4=7 With <5% of Gleason Pattern 4 in Prostate Needle Biopsy Show Similar Failure-free Survival and Adverse Pathology Prevalence to Gleason Score 6 Cases in a Radical Prostatectomy Cohort.

Sato S, Kimura T, Yorozu T, Onuma H, Iwatani K, Egawa S, Ikegami M, Takahashi H.

Am J Surg Pathol. 2019 Aug 20. doi: 10.1097/PAS.0000000000001345. [Epub ahead of print]

PMID:
31436554
2.

Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.

Huang CC, Kong MX, Zhou M, Rosenkrantz AB, Taneja SS, Melamed J, Deng FM.

Am J Surg Pathol. 2014 Aug;38(8):1096-101. doi: 10.1097/PAS.0000000000000235.

PMID:
24832163
3.

Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.

Berg KD, Røder MA, Brasso K, Vainer B, Iversen P.

Scand J Urol. 2014 Apr;48(2):168-76. doi: 10.3109/21681805.2013.821628. Epub 2013 Jul 29.

PMID:
23889119
4.

Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.

Kır G, Seneldir H, Gumus E.

Ann Diagn Pathol. 2016 Feb;20:48-51. doi: 10.1016/j.anndiagpath.2015.10.013. Epub 2015 Dec 2.

PMID:
26750655
5.

Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.

Vellekoop A, Loeb S, Folkvaljon Y, Stattin P.

J Urol. 2014 Feb;191(2):350-7. doi: 10.1016/j.juro.2013.09.034. Epub 2013 Sep 23.

PMID:
24071481
7.

Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy.

Miyake H, Muramaki M, Furukawa J, Tanaka H, Inoue TA, Fujisawa M.

Urol Oncol. 2013 Nov;31(8):1511-6. doi: 10.1016/j.urolonc.2012.05.001. Epub 2012 May 31.

PMID:
22658882
8.

Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort.

Wong LM, Tang V, Peters J, Costello A, Corcoran N.

BJU Int. 2016 Apr;117 Suppl 4:82-7. doi: 10.1111/bju.13460.

9.

Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.

Özsoy M, D'Andrea D, Moschini M, Foerster B, Abufaraj M, Mathieu R, Briganti A, Karakiewicz PI, Roupret M, Seitz C, Czech AK, Susani M, Shariat SF.

Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.

PMID:
29288003
10.

Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.

Perlis N, Sayyid R, Evans A, Van Der Kwast T, Toi A, Finelli A, Kulkarni G, Hamilton R, Zlotta AR, Trachtenberg J, Ghai S, Fleshner NE.

J Urol. 2017 Jan;197(1):75-83. doi: 10.1016/j.juro.2016.07.076. Epub 2016 Jul 22.

PMID:
27457260
11.

Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.

Turker P, Bas E, Bozkurt S, Günlüsoy B, Sezgin A, Postacı H, Turkeri L.

Urol Oncol. 2013 Jan;31(1):93-8. doi: 10.1016/j.urolonc.2010.10.009. Epub 2011 Feb 12.

PMID:
21316989
12.

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM.

BJU Int. 2012 Oct;110(8):1122-8. doi: 10.1111/j.1464-410X.2012.10986.x. Epub 2012 Feb 28.

13.

Impact of Gleason pattern up gradation after radical prostatectomy for carcinoma prostate patients with low biopsy score (≤ 6).

Kulkarni JN, Valsangkar RS, Jadhav YR, Singh DP.

J Cancer Res Ther. 2011 Oct-Dec;7(4):459-62. doi: 10.4103/0973-1482.92021.

14.
15.

Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.

Ellis CL, Partin AW, Han M, Epstein JI.

J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.

PMID:
23727307
16.

The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates.

Schiavina R, Borghesi M, Brunocilla E, Romagnoli D, Diazzi D, Giunchi F, Vagnoni V, Pultrone CV, Dababneh H, Porreca A, Fiorentino M, Martorana G.

Prostate Cancer Prostatic Dis. 2015 Sep;18(3):270-5. doi: 10.1038/pcan.2015.21. Epub 2015 Jun 9.

PMID:
26055663
17.

The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific Mortality.

Ham WS, Chalfin HJ, Feng Z, Trock BJ, Epstein JI, Cheung C, Humphreys E, Partin AW, Han M.

J Urol. 2017 Apr;197(4):1060-1067. doi: 10.1016/j.juro.2016.11.079. Epub 2016 Nov 12.

PMID:
27847296
18.

Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.

Kweldam CF, Kümmerlin IP, Nieboer D, Verhoef EI, Steyerberg EW, Incrocci L, Bangma CH, van der Kwast TH, Roobol MJ, van Leenders GJ.

Eur J Cancer. 2016 Oct;66:26-33. doi: 10.1016/j.ejca.2016.07.012. Epub 2016 Aug 11.

PMID:
27522247
19.

Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.

Rajinikanth A, Manoharan M, Soloway CT, Civantos FJ, Soloway MS.

Urology. 2008 Jul;72(1):177-82. doi: 10.1016/j.urology.2007.10.022. Epub 2008 Feb 15.

PMID:
18279938
20.

Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7.

Verhoef EI, Kweldam CF, Kümmerlin IP, Nieboer D, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ.

Histopathology. 2018 Apr;72(5):760-765. doi: 10.1111/his.13427. Epub 2018 Jan 14.

PMID:
29094386

Supplemental Content

Support Center